BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gatti M, Cojutti PG, Bartoletti M, Tonetti T, Bianchini A, Ramirez S, Pizzilli G, Ambretti S, Giannella M, Mancini R, Siniscalchi A, Viale P, Pea F. Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients. Crit Care 2022;26:178. [PMID: 35701812 DOI: 10.1186/s13054-022-04050-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tritscher P, Delannoy M, Agrinier N, Charmillon A, Degand N, Dellamonica J, Roger C, Leone M, Scala-Bertola J, Novy E. Assessment of current practice for β-lactam therapeutic drug monitoring in French ICUs in 2021: a nationwide cross-sectional survey. J Antimicrob Chemother 2022:dkac291. [PMID: 36059108 DOI: 10.1093/jac/dkac291] [Reference Citation Analysis]
2 Gatti M, Tedeschi S, Trapani F, Ramirez S, Mancini R, Giannella M, Viale P, Pea F. A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis. Antibiotics 2022;11:1037. [DOI: 10.3390/antibiotics11081037] [Reference Citation Analysis]